MSN Lab initiates Phase III clinical trial of Molnupiravir capsules for COVID-19 treatment

The company said it has received its clinical trial approval on May 19, 2021, from the Drug Controller General of India (DCGI) to perform an efficacy and safety study on Molnupiravir capsules on mild to moderate COVID-19 patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fiCZX9
via IFTTT